ENY2
Gene Information
- Official Symbol: ENY2
- Official Name: ENY2 transcription and export complex 2 subunit
- Aliases and Previous Symbols: N/A
- Entrez ID: 56943
- UniProt: Q9NPA8
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: N/A
- UniProt Summary: Involved in mRNA export coupled transcription activation by association with both the TREX-2 and the SAGA complexes. The transcription regulatory histone acetylation (HAT) complex SAGA is a multiprotein complex that activates transcription by remodeling chromatin and mediating histone acetylation and deubiquitination. Within the SAGA complex, participates in a subcomplex that specifically deubiquitinates both histones H2A and H2B. The SAGA complex is recruited to specific gene promoters by activators such as MYC, where it is required for transcription. Required for nuclear receptor-mediated transactivation. The TREX-2 complex functions in docking export-competent ribonucleoprotein particles (mRNPs) to the nuclear entrance of the nuclear pore complex (nuclear basket). TREX-2 participates in mRNA export and accurate chromatin positioning in the nucleus by tethering genes to the nuclear periphery. {ECO:0000269|PubMed:18206972, ECO:0000269|PubMed:21746879}.
Pfam Domains GO Terms
Pfam Domains
| EnY2 |
GO Terms
| DUBm complex |
| transcription export complex 2 |
| negative regulation of insulin secretion involved in cellular response to glucose stimulus |
| nuclear pore nuclear basket |
| SAGA complex |
| poly(A)+ mRNA export from nucleus |
| histone deubiquitination |
| negative regulation of insulin secretion |
| negative regulation of peptide hormone secretion |
| regulation of insulin secretion involved in cellular response to glucose stimulus |
| negative regulation of hormone secretion |
| nuclear receptor transcription coactivator activity |
| transcription elongation from RNA polymerase II promoter |
| DNA-templated transcription, elongation |
| mRNA-containing ribonucleoprotein complex export from nucleus |
| mRNA export from nucleus |
| ribonucleoprotein complex export from nucleus |
| ribonucleoprotein complex localization |
| RNA export from nucleus |
| negative regulation of protein secretion |
| negative regulation of peptide secretion |
| protein export from nucleus |
| mRNA transport |
| nuclear export |
| regulation of insulin secretion |
| negative regulation of protein transport |
| negative regulation of establishment of protein localization |
| RNA transport |
| nucleic acid transport |
| establishment of RNA localization |
| negative regulation of secretion by cell |
| regulation of peptide hormone secretion |
| RNA localization |
| negative regulation of secretion |
| nucleobase-containing compound transport |
| protein-containing complex localization |
| nucleocytoplasmic transport |
| nuclear transport |
| regulation of hormone secretion |
| protein deubiquitination |
| transcription coactivator activity |
| protein modification by small protein removal |
| histone modification |
| covalent chromatin modification |
| chromatin binding |
| regulation of protein secretion |
| transcription by RNA polymerase II |
| negative regulation of transport |
| regulation of peptide secretion |
| regulation of hormone levels |
| transcription, DNA-templated |
| nucleic acid-templated transcription |
| RNA biosynthetic process |
| chromatin organization |
| regulation of protein transport |
| regulation of peptide transport |
| regulation of establishment of protein localization |
| regulation of secretion by cell |
| regulation of secretion |
| regulation of cellular localization |
| protein modification by small protein conjugation or removal |
| intracellular protein transport |
| regulation of protein localization |
| chromosome organization |
| nucleobase-containing compound biosynthetic process |
| heterocycle biosynthetic process |
| aromatic compound biosynthetic process |
| mitochondrion |
| proteolysis |
| organic cyclic compound biosynthetic process |
| negative regulation of cell communication |
| negative regulation of signaling |
| protein transport |
| intracellular transport |
| peptide transport |
| positive regulation of transcription, DNA-templated |
| amide transport |
| cellular protein localization |
| cellular macromolecule localization |
| establishment of protein localization |
| negative regulation of response to stimulus |
| cellular nitrogen compound biosynthetic process |
| positive regulation of nucleic acid-templated transcription |
| positive regulation of RNA biosynthetic process |
| RNA metabolic process |
| cellular macromolecule biosynthetic process |
| positive regulation of RNA metabolic process |
| macromolecule biosynthetic process |
| establishment of localization in cell |
| nitrogen compound transport |
| regulation of transport |
| positive regulation of nucleobase-containing compound metabolic process |
| positive regulation of macromolecule biosynthetic process |
| positive regulation of cellular biosynthetic process |
| positive regulation of gene expression |
| gene expression |
| positive regulation of biosynthetic process |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
Most Correlated Genes in Chemogenomics
| Gene | Correlation |
|---|---|
| NXT1 | 0.642 |
| GFPT1 | 0.623 |
| RPTOR | 0.623 |
| HARS | 0.622 |
| HSPD1 | 0.618 |
| PMM2 | 0.603 |
| GMPPB | 0.603 |
| DPAGT1 | 0.602 |
| CASP9 | 0.593 |
| PLAA | 0.586 |
| APAF1 | 0.584 |
| MEAF6 | 0.584 |
| THG1L | 0.583 |
| CSNK2B | 0.579 |
| PPP2R3C | 0.578 |
| UAP1 | 0.572 |
| ALG5 | 0.57 |
| HCCS | 0.568 |
| TRIAP1 | 0.564 |
| ALG1 | 0.558 |
| RNMT | 0.557 |
| ATP5J | 0.556 |
| CYCS | 0.554 |
| UBQLN1 | 0.553 |
| BAP1 | 0.542 |
| DOHH | 0.539 |
| BAK1 | 0.539 |
| NUPL2 | 0.535 |
| RTCB | 0.534 |
| FAF2 | 0.526 |
| UBE2G2 | 0.524 |
| ADSL | 0.523 |
| UTP23 | 0.523 |
| WDR24 | 0.52 |
| THOC6 | 0.518 |
| ATXN10 | 0.514 |
| MARCH5 | 0.513 |
| UBE2K | 0.51 |
| CTDNEP1 | 0.506 |
| DIABLO | 0.505 |
| MTOR | 0.504 |
| ALG2 | 0.503 |
| GABPA | 0.503 |
| DNAJC3 | 0.502 |
| VHL | 0.502 |
| GTF3A | 0.5 |
| LAMTOR5 | 0.498 |
| EIF4E | 0.495 |
| MFN1 | 0.495 |
| GTF3C3 | 0.493 |
| TGS1 | 0.485 |
| UBA3 | 0.484 |
| SRP14 | 0.484 |
| UHRF1 | 0.483 |
| VDAC2 | 0.483 |
| MAPK14 | 0.481 |
| TRMT5 | 0.48 |
| UBE2J1 | 0.479 |
| PELO | 0.479 |
| RPE | 0.478 |
| ATP5O | 0.476 |
| GTF3C2 | 0.475 |
| KDSR | 0.475 |
| NAE1 | 0.474 |
| DPF2 | 0.474 |
| CCDC101 | 0.473 |
| SERF2 | 0.472 |
| ATP5B | 0.471 |
| ATP5I | 0.471 |
| FGFR1OP | 0.47 |
| TBP | 0.469 |
| SSB | 0.469 |
| TLE4 | 0.469 |
| DAD1 | 0.468 |
| DERL2 | 0.468 |
| TMED10 | 0.468 |
| WDR59 | 0.466 |
| SDHA | 0.465 |
| EPRS | 0.463 |
| ALG6 | 0.462 |
| DHPS | 0.461 |
| KCTD5 | 0.461 |
| CCT7 | 0.46 |
| THOC3 | 0.458 |
| VEZT | 0.458 |
| DDHD2 | 0.457 |
| MED16 | 0.455 |
| ROMO1 | 0.455 |
| ALG13 | 0.454 |
| RPP21 | 0.452 |
| SEH1L | 0.452 |
| NARS | 0.452 |
| CBFB | 0.452 |
| SEC16A | 0.449 |
| ABCF3 | 0.448 |
| PAX5 | 0.446 |
| PAM16 | 0.446 |
| ID3 | 0.446 |
| MRPS33 | 0.446 |
| GTF3C6 | 0.445 |
| DR1 | 0.445 |
| DOLK | 0.444 |
| TMEM41B | 0.444 |
| BTAF1 | 0.443 |
| OSGEP | 0.443 |
| ATP5A1 | 0.443 |
| MANF | 0.442 |
| AARS | 0.44 |
| TXNRD1 | 0.438 |
| EIF3F | 0.438 |
| NSD1 | 0.438 |
| MARS | 0.438 |
| UBA5 | 0.437 |
| HAUS8 | 0.436 |
| ATP5F1 | 0.434 |
| ORAOV1 | 0.434 |
| SPCS2 | 0.434 |
| CARS | 0.433 |
| PCBP2 | 0.433 |
| SUV420H1 | 0.433 |
| USO1 | 0.43 |
| TSEN54 | 0.429 |
| TP53 | 0.428 |
| DERL1 | 0.427 |
| CRLS1 | 0.427 |
| MBTPS2 | 0.427 |
| SEC61G | 0.426 |
| OTUD5 | 0.426 |
| PPA2 | 0.425 |
| SRP68 | 0.424 |
| LAMTOR4 | 0.424 |
| SEC62 | 0.424 |
| RAD23B | 0.423 |
| FBXO11 | 0.421 |
| NSMCE1 | 0.42 |
| GTF3C4 | 0.419 |
| MED4 | 0.418 |
| ALG14 | 0.418 |
| SLC25A26 | 0.417 |
| TTI2 | 0.417 |
| TBCA | 0.417 |
| GFER | 0.415 |
| ATP2A2 | 0.414 |
| DHDDS | 0.414 |
| THOC7 | 0.412 |
| ALG3 | 0.412 |
| NUP50 | 0.411 |
| LSMD1 | 0.411 |
| MIOS | 0.409 |
| TIMM13 | 0.408 |
| YARS | 0.408 |
| PRKRIR | 0.407 |
| SLC35B1 | 0.407 |
| ATAD1 | 0.407 |
| VRK1 | 0.407 |
| DARS2 | 0.405 |
| TTI1 | 0.405 |
| MRPS14 | 0.403 |
| SUPV3L1 | 0.403 |
| URM1 | 0.402 |
| GEMIN5 | 0.401 |
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 0/726
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/25 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/15 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/14 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/7 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Essentiality in NALM6
- Essentiality Rank: 3515
- Expression level (log2 read counts): 5.68
Expression Distribution
ENY2 Expression in NALM6 Cells: 5.68